Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers January 20, 2019
Pharmacy Choice - News - Front Page Healthcare News - January 20, 2019

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

1/19/19 - 3D Printing Medical Devices Market to Expand at 17.7% of CAGR Due to Ardent of Advanced Technology Through Research and Development: 3D Printing Medical Devices Market (Component - Printers, Materials, and Software and Services; Technology - Electron
Albany, NY 01/19/2019 A stew of medium and small scale industries have barged into the global 3 D printing medical devices market, making it a high competition amongst the players, notices Transparency Market Research in a newly published report. Some of the key players in the global 3 D printing medical device market are Materialise NC, SLM
1/19/19 - Acute Hospitalization Prior to Dialysis Predicts Post-Dialysis Harm, UC Research Shows
The University of Cincinnati issued the following news:. Hospitalizations in the pre-dialysis period adversely impact dialysis outcomes according to new research from the University of Cincinnati. "Given that patients with chronic kidney disease, a precursor to end stage kidney disease, face an increasing burden of hospitalizations, our study focu
1/19/19 - AIVITA gets IND nod for Phase 1B melanoma trial [Syrian Arab News Agency]
AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application for a Phase 1 B clinical trial investigating the Company`s ROOT OF CANCER technology in patients with metastatic melanoma. AIVITA`s ROOT OF CANCER...
1/19/19 - Alphabet's health division gets clearance for on-demand ECG feature in smartwatch [Asian News International]
California, January 19: After Apple, Google' s parent company Alphabet is working its way towards bringing health at the center of its products. Now, the company's health division Verily has reportedly received FDA 510 clearance for its Study smartwatch for an on-demand ECG feature. The feature is increasingly becoming a standard for a lot of manuf
1/19/19 - Antibody Drug Conjugates Market Set to Garner Staggering Revenues by 2020
Albany, NY 01/19/2019 The global Antibody Drug Conjugates Market are very effective biopharmaceuticals developed as the targeted therapeutic helpful in the treatment of Cancer. Antibody drugs conjugates are further designed to eradicate the cancer cells without harming the normal cells. Of these, Adcertis drug segment dominate this market due
1/19/19 - Automated Microbiology Testing Market: North America is the most dominating region for this market
"Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on the gamut of sectors across the globe" The aging workforce in laboratory tests, the growing demand for high quality laboratory services and the growing need for fast results will lead to the expansion of the global market fo
1/19/19 - Bee Pollen Supplements Market Soaring Demand Assures Motivated Revenue Share During 2018 to 2026: Fact.MR has announced the addition of the Bee Pollen Supplements Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 201
Rockville, MD 01/19/2019 Bee pollen is a mixture of pollens picked by bees, bee saliva, and some nectar. Bee pollen Supplements have been popular for its high nutrient content and medicinal properties. German Federal Board of Health has recognized bee pollen supplements as medicine, owing to its medicinal benefits.
1/19/19 - Biosimilar Drugs Market - a Cost-Saving Option to Expensive Biologics: Overview of How Much Have CMOs Benefited from Biosimilars
Albany, NY 01/19/2019 Biosimilars are drugs that are highly similar but not identical to branded innovator biologics: large molecule, immunogenic drugs produced from living cells. Innovator biologics are the first to be approved, and when their patent protection expires, biosimilars may be approved, in a similar way to small molecule branded
1/19/19 - Breathing Equipment Market 2019-2025: Analyzed by Business Growth, Development Factors, Applications and Future Prospects, Top Keyplayers -MSA,RSG Safety &
Maharashtra, India 01/19/2019 Breathing Equipment Market. Breathing equipment is commonly used at instances where there is a possibility of exposure to fire, harmful chemicals and biological hazards; it is also used in adventure sports and at hospitals. For people in a situation of risk, breathing equipment is often used as a control measure.
1/19/19 - Business Digest
Waltham-based AMAG Pharmaceuticals said it has completed a previously announced acquisition of Perosphere Pharmaceuticals, a private biopharmaceutical company. Through this acquisition, AMAG adds ciraparantag to its development portfolio. Ciraparantag has been granted fast track review designation by the U.S. Food and Drug Administration and has...
1/19/19 - Cala Health launches trial for Cala Two neurostim device for essential tremor [Tehran Times (Iran)]
Cala Health last month launched a clinical trial of the latest version of its wearable neurostimulator for treating essential tremor, eyeing extended use of the wrist-worn device. The Burlingame, Calif.- based company won de novo clearance from the FDA last April for the Cala One device for transient relief in adults with essential tremor.
1/19/19 - Cancer Comorbidities Adversely Associated With Clinical Trial Participation [T-break Tech (Middle East)]
The American Society of Clinical Oncology, Friends of Cancer Research, and the US Food and Drug Administration recently recommended modernizing criteria related to comorbidities routinely used to exclude patients from cancer clinical trials. The goal was to design clinical trial eligibility such that trial results better reflect real-world cancer..
1/19/19 - Cardiovascular Surgical Devices Market Clinical Analysis and Global Demand 2019
Harrisburg, NC 01/19/2019 Cardiovascular Surgical Devices Market Report is newly introduced the truth-finding of Cardiovascular Surgical Devices Market that gives meticulous investigation of contemporary situation of the market size, share, demand, growth, developments, and forecast inside the coming years. The key manufacturers in the...
1/19/19 - Cellular Biomedicine Group`s AlloJoin Therapy for Knee Osteoarthritis (KOA) Becomes the First Stem Cell Drug Application Approved in China for Phase II Clinical Trials [Sport360]
Cellular Biomedicine Group, Inc., a biopharmaceutical firm engaged in the development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today announced that its off-the-shelf allogeneic adipose-derived mesenchymal progenitor cell AlloJoin therapy for Knee Osteoarthritis has been approved as the first stem cell KOA...
1/19/19 - Cervical Cancer Diagnostic Tests Market Growth by 2025: Revenue, Gross Margin and Market Shares, Demands, Types, Industry Demands
Pune, India 01/18/2019 Cervical Cancer Diagnostic Tests Market Report 2019. The following manufacturers are covered in this report, with sales, revenue, market share for each company: Abbott Laboratories BD Medical Roche Molecular Diagnostics Hologic Qiagen Quest Diagnostics BioMerieux Cepheid Arbor Vita Trovagene DAAN Gene Delphi Bioscience.
1/19/19 - Clinical Laboratory Services Market2019 Clinical Advancement and Precise Outlook-DaVita Healthcare Partners (US), Eurofins Scientific, Unilabs, Synlab International
Harrisburg, NC 01/19/2019 Global Clinical Laboratory Services Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2025 This report tracks the major market events including product launches, development trends, mergers& acquisitions and the innovative business strategies opted by key market players. The global Clinical Lab
1/19/19 - Cochlear Implants Market 2019 by Size, Share, Geographic Analysis, Leading Providers as Advanced Bionics AG, MED-El, Cochlear Ltd, GAES M?DICA, etc
"Cochlear Implants Market" Market Research Future Has Launched a New Report on the Global Cochlear Implants Market to provide readers with a clear view of the market s likely growth trajectory over the coming years. Global Cochlear Implants Market is anticipated to grow at a CAGR of 9.86% and is due to reach USD 3,203.8 Mn over the forecast peri
1/19/19 - Conclusion Of A Non-exclusive Discount Agreement According To 130a Abs. 8 Sgb V On The Active Ingredient Clonazepam, Atc N03ae01, For The Period 1.2.2019-31.1.2021 [TendersInfo (India)]
Dak-gesundheit assumes that this procedure does not fall within the scope of antitrust law due to the lack of a selection decision and thus the non-discriminatory access of all pharmaceutical companies. irrespective of this, it automatically ends with the entry into force of the exclusive contract for clonazepam, atc n03ae01, as a result of a forma
1/19/19 - Conclusion Of A Non-exclusive Discount Agreement According To 130a Abs. 8 Sgb V On The Active Ingredient Everolimus, Atc L01xe10, For The Period 1.2.2019 - 31.1.2021 [TendersInfo (India)]
Dak-gesundheit assumes that this procedure does not fall within the scope of antitrust law due to the lack of a selection decision and thus the non-discriminatory access of all pharmaceutical companies. irrespective of this, it automatically ends with the entry into force of the exclusive contract for everolimus, atc l01xe10, as a result of a forma
1/19/19 - Conclusion Of A Non-exclusive Discount Agreement According To 130a Abs. 8 Sgb V On The Active Ingredient Formoterol (exclusively Dos), Atc R03ac13, For The Period 1.2.2019 - 31.12.2020 [TendersInfo (India)]
Dak-gesundheit assumes that this procedure does not fall within the scope of antitrust law due to the lack of a selection decision and thus non-discriminatory access of all pharmaceutical companies, and automatically ends with the entry into force of the formoterol exclusive agreement, atc r03ac13, following a formal award procedure in accordance w
1/19/19 - Conclusion Of A Non-exclusive Discount Agreement According To 130a Abs. 8 Sgb V On The Active Substance Aripiprazole, Atc N05ax12 (only Dafo For Intramuscular Injection), For The Period 1.2.2019 - 31.1.2021 [TendersInfo (India)]
The dak-g assumes that this procedure does not fall within the scope of antitrust law due to the lack of a selection decision and thus the non-discriminatory access of all pharmaceutical companies. irrespective of this, it automatically ends with the entry into force of the exclusive agreement on aripiprazole as a result of a formal award procedure
1/19/19 - Conclusion Of A Non-exclusive Discount Agreement According To 130a Abs. 8 Sgb V On The Active Substance Calcipotriol And Betamethasone, Atc D05ax22, For The Period 1.2.2019 - 31.1.2021 [TendersInfo (India)]
Dak-gesundheit assumes that this procedure does not fall within the scope of antitrust law due to the lack of a selection decision and thus the non-discriminatory access of all pharmaceutical companies. irrespective of this, it automatically ends with the entry into force of the exclusive agreement on calcipotriol and betamethasone, atc d05ax22, as
1/19/19 - Conclusion Of A Non-exclusive Discount Agreement According To 130a Abs. 8 Sgb V On The Active Substance Lipegfilgrastim (atc L03aa14), For The Period 1.2.2019 - 31.1.2021 [TendersInfo (India)]
The dak-g assumes that this procedure does not fall within the scope of antitrust law due to the lack of a selection decision and thus the non-discriminatory access of all pharmaceutical companies. irrespective of this, it automatically ends with the entry into force of the exclusive contract for lipegfilgrastim as a result of a formal award proced
1/19/19 - Conclusion Of A Non-exclusive Discount Agreement Pursuant To 130a (8) Sgb V On Medicines Containing The Active Substance Darunavir (atc Code: J05ae10) [TendersInfo (India)]
For the active substance darunavir, the aok- die gesundheitskasse fr niedersachsen offers rebate contracts to all interested pharmaceutical companies for the period up to the entry into force of exclusive contracts following a formal award procedure in accordance with the regulations of the 4th part of the gwb on. the contracts are concluded as par
1/19/19 - Conclusion Of A Non-exclusive Discount Agreement Pursuant To 130a (8) Sgb V On The Active Substance Gefitinib (atc L01xe02), For The Period 1.2.2019 - 31.1.2021 [TendersInfo (India)]
The dak-g assumes that this procedure does not fall within the scope of antitrust law due to the lack of a selection decision and thus the non-discriminatory access of all pharmaceutical companies. irrespective of this, it automatically ends with the entry into force of the exclusive agreement on gefitinib, following a formal award procedure in acc
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2019 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415